857412 | IG8
N-((2S,3R)-3-hydroxy-1-oxo-1-(tridecylamino)butan-2-yl)-4-methoxy-1H-indole-2-carboxamide

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
IG8
N-((2S,3R)-3-hydroxy-1-oxo-1-(tridecylamino)butan-2-yl)-4-methoxy-1H-indole-2-carboxamide
C27H43N3O4
C 68.47%, H 9.15%, N 8.87%, O 13.51%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Coe GL, Redd PS, Paschall AV, Lu C, Gu L, Cai H, Albers T, Lebedyeva IO, Liu K. Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes. Sci Rep. 2016 Aug 4;6:30816. doi: 10.1038/srep30816.
PubMed ID: 27487939